nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—ADRB2—autistic disorder	0.85	1	CbGaD
Labetalol—Isoprenaline—MAPK1—autistic disorder	0.00143	0.15	CrCbGaD
Labetalol—Dobutamine—COMT—autistic disorder	0.00118	0.123	CrCbGaD
Labetalol—Benazepril—MTHFR—autistic disorder	0.000788	0.0822	CrCbGaD
Labetalol—Salmeterol—ADRB2—autistic disorder	0.000765	0.0798	CrCbGaD
Labetalol—Fenoterol—ADRB2—autistic disorder	0.000736	0.0768	CrCbGaD
Labetalol—Ritodrine—ADRB2—autistic disorder	0.000736	0.0768	CrCbGaD
Labetalol—Arbutamine—ADRB2—autistic disorder	0.000689	0.0718	CrCbGaD
Labetalol—Formoterol—ADRB2—autistic disorder	0.000668	0.0697	CrCbGaD
Labetalol—Arformoterol—ADRB2—autistic disorder	0.000668	0.0697	CrCbGaD
Labetalol—Dobutamine—ADRB2—autistic disorder	0.000634	0.0661	CrCbGaD
Labetalol—Isoprenaline—ADRB2—autistic disorder	0.00036	0.0375	CrCbGaD
Labetalol—Salsalate—PTGS2—autistic disorder	0.000324	0.0338	CrCbGaD
Labetalol—Fenoprofen—PTGS2—autistic disorder	0.000268	0.0279	CrCbGaD
Labetalol—Flurbiprofen—PTGS2—autistic disorder	0.000175	0.0182	CrCbGaD
Labetalol—Ketoprofen—PTGS2—autistic disorder	0.000158	0.0165	CrCbGaD
Labetalol—ADRB3—Signaling Pathways—PDE4B—autistic disorder	7.67e-05	0.000546	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—AVP—autistic disorder	7.66e-05	0.000545	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	7.56e-05	0.000538	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PDE4B—autistic disorder	7.54e-05	0.000537	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—OPRM1—autistic disorder	7.47e-05	0.000531	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—OPRM1—autistic disorder	7.43e-05	0.000529	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—HTR2A—autistic disorder	7.37e-05	0.000524	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—OPRM1—autistic disorder	7.31e-05	0.00052	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HTR1B—autistic disorder	7.3e-05	0.00052	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—OXT—autistic disorder	7.3e-05	0.00052	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GABBR2—autistic disorder	7.25e-05	0.000516	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—BTD—autistic disorder	7.21e-05	0.000513	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—HTR2A—autistic disorder	7.21e-05	0.000513	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PLA2G4A—autistic disorder	7.2e-05	0.000512	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HTR1B—autistic disorder	7.14e-05	0.000508	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—OXT—autistic disorder	7.14e-05	0.000508	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GABBR2—autistic disorder	7.1e-05	0.000505	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—HTR2A—autistic disorder	7.02e-05	0.000499	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GZMB—autistic disorder	6.8e-05	0.000484	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD1—autistic disorder	6.79e-05	0.000483	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD1—autistic disorder	6.64e-05	0.000473	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HTR1B—autistic disorder	6.63e-05	0.000472	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—OXT—autistic disorder	6.63e-05	0.000472	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—OXT—autistic disorder	6.6e-05	0.00047	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HTR1B—autistic disorder	6.6e-05	0.00047	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD3—autistic disorder	6.57e-05	0.000468	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HTR1B—autistic disorder	6.49e-05	0.000462	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—OXT—autistic disorder	6.49e-05	0.000462	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR1D—autistic disorder	6.47e-05	0.00046	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—IL5—autistic disorder	6.44e-05	0.000458	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD3—autistic disorder	6.43e-05	0.000458	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HTR2A—autistic disorder	6.37e-05	0.000453	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CALCA—autistic disorder	6.36e-05	0.000452	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR1D—autistic disorder	6.32e-05	0.00045	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—IL5—autistic disorder	6.29e-05	0.000448	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRLR—autistic disorder	6.22e-05	0.000443	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CALCA—autistic disorder	6.22e-05	0.000442	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD1—autistic disorder	6.16e-05	0.000439	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—PRKCB—autistic disorder	6.15e-05	0.000438	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD1—autistic disorder	6.14e-05	0.000437	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TSC1—autistic disorder	6.14e-05	0.000437	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TDO2—autistic disorder	6.13e-05	0.000436	CbGpPWpGaD
Labetalol—CYP2D6—Biological oxidations—POMC—autistic disorder	6.11e-05	0.000435	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRLR—autistic disorder	6.09e-05	0.000433	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD1—autistic disorder	6.03e-05	0.000429	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GRM8—autistic disorder	6.01e-05	0.000428	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD3—autistic disorder	5.97e-05	0.000425	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NTRK2—autistic disorder	5.97e-05	0.000425	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD3—autistic disorder	5.94e-05	0.000423	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—PIK3CG—autistic disorder	5.89e-05	0.000419	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—POMC—autistic disorder	5.88e-05	0.000419	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GRM8—autistic disorder	5.88e-05	0.000418	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL5—autistic disorder	5.84e-05	0.000416	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD3—autistic disorder	5.84e-05	0.000416	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—WNT2—autistic disorder	5.82e-05	0.000414	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL5—autistic disorder	5.82e-05	0.000414	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CALCA—autistic disorder	5.77e-05	0.000411	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—DHCR7—autistic disorder	5.76e-05	0.00041	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—POMC—autistic disorder	5.76e-05	0.00041	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CALCA—autistic disorder	5.74e-05	0.000409	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GHR—autistic disorder	5.73e-05	0.000408	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL5—autistic disorder	5.72e-05	0.000407	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—WNT2—autistic disorder	5.69e-05	0.000405	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PDE4A—autistic disorder	5.65e-05	0.000402	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CALCA—autistic disorder	5.65e-05	0.000402	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GHR—autistic disorder	5.61e-05	0.000399	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—POMC—autistic disorder	5.6e-05	0.000399	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PRKCB—autistic disorder	5.59e-05	0.000397	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PDE4A—autistic disorder	5.53e-05	0.000393	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—EXT1—autistic disorder	5.46e-05	0.000389	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SLC6A8—autistic disorder	5.46e-05	0.000389	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PIK3CG—autistic disorder	5.35e-05	0.00038	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—ADRB2—autistic disorder	5.33e-05	0.000379	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AVPR1A—autistic disorder	5.29e-05	0.000377	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—DAO—autistic disorder	5.21e-05	0.000371	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AVPR1A—autistic disorder	5.18e-05	0.000368	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GRM5—autistic disorder	5.11e-05	0.000364	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—VIP—autistic disorder	5.11e-05	0.000364	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—POMC—autistic disorder	5.09e-05	0.000362	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PRL—autistic disorder	5.07e-05	0.000361	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AVP—autistic disorder	5e-05	0.000356	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GRM5—autistic disorder	5e-05	0.000356	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—VIP—autistic disorder	5e-05	0.000356	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—UPB1—autistic disorder	5e-05	0.000356	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—OXTR—autistic disorder	4.95e-05	0.000352	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SCT—autistic disorder	4.9e-05	0.000349	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AVP—autistic disorder	4.9e-05	0.000348	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—OXTR—autistic disorder	4.84e-05	0.000345	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—ADRB2—autistic disorder	4.84e-05	0.000344	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ADRB2—autistic disorder	4.81e-05	0.000343	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SCT—autistic disorder	4.79e-05	0.000341	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GABBR1—autistic disorder	4.67e-05	0.000333	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADM—autistic disorder	4.67e-05	0.000333	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ASMT—autistic disorder	4.65e-05	0.000331	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTM5—autistic disorder	4.65e-05	0.000331	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EIF4E—autistic disorder	4.59e-05	0.000327	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GABBR1—autistic disorder	4.57e-05	0.000325	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ADM—autistic disorder	4.57e-05	0.000325	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PDE4B—autistic disorder	4.56e-05	0.000324	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AVP—autistic disorder	4.54e-05	0.000323	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AVP—autistic disorder	4.52e-05	0.000322	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IGF2—autistic disorder	4.5e-05	0.00032	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EIF4E—autistic disorder	4.49e-05	0.00032	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PDE4B—autistic disorder	4.46e-05	0.000317	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AVP—autistic disorder	4.45e-05	0.000316	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—OPRM1—autistic disorder	4.41e-05	0.000314	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SLC25A12—autistic disorder	4.37e-05	0.000311	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—OPRM1—autistic disorder	4.32e-05	0.000307	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PLA2G4A—autistic disorder	4.27e-05	0.000304	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PLA2G4A—autistic disorder	4.25e-05	0.000303	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SLC19A1—autistic disorder	4.25e-05	0.000302	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PLA2G4A—autistic disorder	4.18e-05	0.000297	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HTR2A—autistic disorder	4.16e-05	0.000296	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—IL2—autistic disorder	4.14e-05	0.000295	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MEF2C—autistic disorder	4.14e-05	0.000294	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HTR2A—autistic disorder	4.07e-05	0.00029	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GZMB—autistic disorder	4.03e-05	0.000287	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ITGB3—autistic disorder	4.03e-05	0.000287	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GZMB—autistic disorder	3.95e-05	0.000281	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—OXT—autistic disorder	3.92e-05	0.000279	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR1B—autistic disorder	3.92e-05	0.000279	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—OXT—autistic disorder	3.83e-05	0.000273	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR1B—autistic disorder	3.83e-05	0.000273	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ADSL—autistic disorder	3.79e-05	0.00027	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HTR2A—autistic disorder	3.78e-05	0.000269	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HTR2A—autistic disorder	3.76e-05	0.000268	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL2—autistic disorder	3.76e-05	0.000268	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—XDH—autistic disorder	3.71e-05	0.000264	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HTR2A—autistic disorder	3.7e-05	0.000263	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PRKCB—autistic disorder	3.65e-05	0.00026	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—STX1A—autistic disorder	3.65e-05	0.000259	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NPAS2—autistic disorder	3.65e-05	0.000259	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TSC1—autistic disorder	3.64e-05	0.000259	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD1—autistic disorder	3.64e-05	0.000259	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TSC2—autistic disorder	3.58e-05	0.000254	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PRKCB—autistic disorder	3.57e-05	0.000254	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TSC1—autistic disorder	3.56e-05	0.000253	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD1—autistic disorder	3.56e-05	0.000253	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NTRK2—autistic disorder	3.54e-05	0.000252	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD3—autistic disorder	3.53e-05	0.000251	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TCN2—autistic disorder	3.52e-05	0.000251	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APOE—autistic disorder	3.5e-05	0.000249	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—LEP—autistic disorder	3.5e-05	0.000249	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CG—autistic disorder	3.49e-05	0.000249	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NTRK2—autistic disorder	3.47e-05	0.000247	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL5—autistic disorder	3.45e-05	0.000246	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD3—autistic disorder	3.45e-05	0.000245	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CG—autistic disorder	3.42e-05	0.000243	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CALCA—autistic disorder	3.41e-05	0.000243	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL5—autistic disorder	3.38e-05	0.00024	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ADA—autistic disorder	3.36e-05	0.000239	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CALCA—autistic disorder	3.34e-05	0.000237	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—POMC—autistic disorder	3.33e-05	0.000237	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PRKCB—autistic disorder	3.32e-05	0.000236	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PRKCB—autistic disorder	3.3e-05	0.000235	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—POMC—autistic disorder	3.25e-05	0.000231	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PRKCB—autistic disorder	3.24e-05	0.000231	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CG—autistic disorder	3.17e-05	0.000226	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APC—autistic disorder	3.16e-05	0.000225	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CG—autistic disorder	3.16e-05	0.000225	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—EGF—autistic disorder	3.12e-05	0.000222	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CG—autistic disorder	3.1e-05	0.000221	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—RORA—autistic disorder	3.06e-05	0.000218	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—POMC—autistic disorder	3.02e-05	0.000215	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRL—autistic disorder	3.01e-05	0.000214	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—POMC—autistic disorder	3.01e-05	0.000214	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—POMC—autistic disorder	2.95e-05	0.00021	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRL—autistic disorder	2.95e-05	0.00021	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IGF1—autistic disorder	2.89e-05	0.000206	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—MAPK1—autistic disorder	2.88e-05	0.000205	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MAOB—autistic disorder	2.87e-05	0.000204	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADRB2—autistic disorder	2.86e-05	0.000203	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SERPINE1—autistic disorder	2.75e-05	0.000195	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AVP—autistic disorder	2.68e-05	0.000191	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF2—autistic disorder	2.67e-05	0.00019	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TPH2—autistic disorder	2.67e-05	0.00019	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AVP—autistic disorder	2.63e-05	0.000187	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—DPYD—autistic disorder	2.63e-05	0.000187	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF2—autistic disorder	2.61e-05	0.000186	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PLA2G4A—autistic disorder	2.52e-05	0.00018	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PLA2G4A—autistic disorder	2.47e-05	0.000176	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—IL2—autistic disorder	2.46e-05	0.000175	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MEF2C—autistic disorder	2.46e-05	0.000175	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CACNA1C—autistic disorder	2.44e-05	0.000174	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—IL2—autistic disorder	2.41e-05	0.000171	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MEF2C—autistic disorder	2.4e-05	0.000171	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ITGB3—autistic disorder	2.39e-05	0.00017	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ITGB3—autistic disorder	2.34e-05	0.000167	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HRAS—autistic disorder	2.31e-05	0.000164	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR2A—autistic disorder	2.23e-05	0.000159	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL2—autistic disorder	2.23e-05	0.000159	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL2—autistic disorder	2.22e-05	0.000158	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—DHFR—autistic disorder	2.22e-05	0.000158	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL6—autistic disorder	2.21e-05	0.000157	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR2A—autistic disorder	2.19e-05	0.000155	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL2—autistic disorder	2.18e-05	0.000155	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TSC2—autistic disorder	2.12e-05	0.000151	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PTEN—autistic disorder	2.09e-05	0.000149	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOE—autistic disorder	2.08e-05	0.000148	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LEP—autistic disorder	2.08e-05	0.000148	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TSC2—autistic disorder	2.08e-05	0.000148	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOE—autistic disorder	2.03e-05	0.000145	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LEP—autistic disorder	2.03e-05	0.000145	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRKCB—autistic disorder	1.96e-05	0.000139	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRKCB—autistic disorder	1.92e-05	0.000136	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APC—autistic disorder	1.87e-05	0.000133	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CG—autistic disorder	1.87e-05	0.000133	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EGF—autistic disorder	1.85e-05	0.000132	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APC—autistic disorder	1.83e-05	0.00013	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CG—autistic disorder	1.83e-05	0.00013	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EGF—autistic disorder	1.81e-05	0.000129	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—POMC—autistic disorder	1.78e-05	0.000127	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—POMC—autistic disorder	1.75e-05	0.000124	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP19A1—autistic disorder	1.74e-05	0.000124	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF1—autistic disorder	1.72e-05	0.000122	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—MAPK1—autistic disorder	1.71e-05	0.000122	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAPK1—autistic disorder	1.7e-05	0.000121	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF1—autistic disorder	1.68e-05	0.000119	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—MAPK1—autistic disorder	1.67e-05	0.000119	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SERPINE1—autistic disorder	1.63e-05	0.000116	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—COMT—autistic disorder	1.62e-05	0.000115	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTP1—autistic disorder	1.61e-05	0.000115	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MAOA—autistic disorder	1.61e-05	0.000114	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SERPINE1—autistic disorder	1.59e-05	0.000113	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CAT—autistic disorder	1.57e-05	0.000111	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PLA2G4A—autistic disorder	1.48e-05	0.000105	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTM1—autistic disorder	1.48e-05	0.000105	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GPX1—autistic disorder	1.42e-05	0.000101	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HRAS—autistic disorder	1.37e-05	9.76e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HRAS—autistic disorder	1.36e-05	9.71e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HRAS—autistic disorder	1.34e-05	9.54e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL2—autistic disorder	1.32e-05	9.38e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6—autistic disorder	1.31e-05	9.34e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MTHFR—autistic disorder	1.31e-05	9.3e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6—autistic disorder	1.31e-05	9.29e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL2—autistic disorder	1.29e-05	9.18e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6—autistic disorder	1.28e-05	9.13e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PTEN—autistic disorder	1.24e-05	8.83e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOE—autistic disorder	1.22e-05	8.66e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PTEN—autistic disorder	1.21e-05	8.64e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CG—autistic disorder	1.1e-05	7.81e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—POMC—autistic disorder	1.05e-05	7.44e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAPK1—autistic disorder	1.01e-05	7.18e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAPK1—autistic disorder	9.87e-06	7.02e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS2—autistic disorder	8.34e-06	5.93e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HRAS—autistic disorder	8.1e-06	5.76e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HRAS—autistic disorder	7.92e-06	5.64e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6—autistic disorder	7.75e-06	5.52e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6—autistic disorder	7.58e-06	5.4e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTEN—autistic disorder	7.27e-06	5.17e-05	CbGpPWpGaD
